Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Completed
CT.gov ID
NCT00819026
Collaborator
(none)
15
1
58
0.3
Study Details
Study Description
Brief Summary
Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
15 participants
Time Perspective:
Cross-Sectional
Study Start Date
:
Oct 1, 2008
Actual Primary Completion Date
:
Aug 1, 2013
Actual Study Completion Date
:
Aug 1, 2013
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- HCV infected on immunosuppression
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Wisconsin | Madison | Wisconsin | United States | 53706 |
Sponsors and Collaborators
- University of Wisconsin, Madison
Investigators
- Principal Investigator: Robert Striker, University of Wisconsin, Madison
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00819026
Other Study ID Numbers:
- UWisHCV-1
First Posted:
Jan 8, 2009
Last Update Posted:
Dec 10, 2014
Last Verified:
Dec 1, 2014